MDVL Insider Trading (MedAvail)
Insider Ownership Percentage: 3.70%
Insider Buying (Last 12 Months): $1,420,596.15
Insider Selling (Last 12 Months): $0.00
MedAvail Insider Trading History Chart
MedAvail Share Price & Price History
As of 06/21/2021 03:21 PM ET
Could This Seattle Pot Stock SOAR as Legal Weed Market Expands?
Fifteen states plus the District of Columbia now permit the recreational use of cannabis and Congress is on track to decriminalize marijuana possession on the federal level. As a result, the North American cannabis market is expected to TRIPLE in size from $30 billion to $100 billion by the year 2027 – and one Seattle manufacturer is poised to cash in!
Details in Brand-New Special Report!
MedAvail Insider Trading History
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|12/28/2020||Wtt-Medavail Ltd Abg||Major Shareholder||Buy||7,107||$13.98||$99,355.86|| |
|12/23/2020||Wtt-Medavail Ltd Abg||Major Shareholder||Buy||21,700||$13.99||$303,583.00|| |
|12/21/2020||Wtt-Medavail Ltd Abg||Major Shareholder||Buy||16,277||$13.31||$216,646.87|| |
|12/18/2020||Wtt-Medavail Ltd Abg||Major Shareholder||Buy||18,600||$13.59||$252,774.00|| |
|12/16/2020||Wtt-Medavail Ltd Abg||Major Shareholder||Buy||28,429||$13.06||$371,282.74|| |
|12/14/2020||Wtt-Medavail Ltd Abg||Major Shareholder||Buy||14,457||$12.24||$176,953.68|| |
SEC Filings (Institutional Ownership Changes) for MedAvail (NASDAQ:MDVL)
83.60% of MedAvail stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.
Institutional Buying and Selling by Quarter
MedAvail Institutional Trading History
Data available starting January 2016
|Reporting Date||Hedge Fund||Shares Held||Market Value||% of Portfolio||Quarterly Change in Shares||Ownership in Company||Details|
|5/19/2021||Squarepoint Ops LLC||14,372||$0.20M||0.0%||+35.3%||0.045%|
|5/18/2021||Millennium Management LLC||109,614||$1.54M||0.0%||+231.0%||0.343%|
|5/17/2021||Endurant Capital Management LP||229,767||$3.22M||0.8%||+262.1%||0.719%|
|5/17/2021||Goldman Sachs Group Inc.||19,945||$0.28M||0.0%||N/A||0.062%|
|5/12/2021||Geode Capital Management LLC||13,175||$0.18M||0.0%||N/A||0.041%|
|5/12/2021||Pura Vida Investments LLC||2,342,213||$31.63M||0.9%||-9.5%||7.332%|
|5/12/2021||Burleson & Company LLC||2,300||$32K||0.0%||N/A||0.007%|
|5/10/2021||Royce & Associates LP||116,740||$1.63M||0.0%||+121.7%||0.365%|
|5/10/2021||Cigna Investments Inc. New||514,668||$7.21M||0.5%||N/A||1.611%|
|2/16/2021||Squarepoint Ops LLC||10,623||$0.16M||0.0%||N/A||1.046%|
|2/16/2021||Endurant Capital Management LP||63,455||$0.96M||0.3%||N/A||6.246%|
|2/16/2021||BBR Partners LLC||15,237||$0.23M||0.0%||N/A||1.500%|
|2/16/2021||Pura Vida Investments LLC||2,588,014||$36.88M||1.3%||N/A||254.726%|
|2/16/2021||ExodusPoint Capital Management LP||31,319||$0.47M||0.0%||N/A||3.083%|
|2/11/2021||Monashee Investment Management LLC||230,568||$3.47M||0.5%||N/A||22.694%|
|2/8/2021||Royce & Associates LP||52,649||$0.79M||0.0%||N/A||5.182%|
MedAvail Holdings, Inc. operates as a technology enabled pharmacy company that embeds automated pharmacy services directly into clinics and other points of care through its proprietary technology. The company provides turnkey services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations. It also operates SpotRx, a telehealth platform that delivers remote pharmacist consultations through an on-site dispensing kiosk, supplemented with home delivery. MedAvail Holdings, Inc. is based in Mississauga, Canada.
50 Day Range
52 Week Range
Who are the company insiders with the largest holdings of MedAvail?
MedAvail's top insider investors include:
- Wtt-Medavail Ltd Abg (Major Shareholder)
Who are the major institutional investors of MedAvail?
MedAvail's top institutional shareholders include:
- Pura Vida Investments LLC — 7.33%
- Cigna Investments Inc. New — 1.61%
- Endurant Capital Management LP — 0.72%
- Royce & Associates LP — 0.37%
- Millennium Management LLC — 0.34%
- Goldman Sachs Group Inc. — 0.06%
Which institutional investors are selling MedAvail stock?
In the previous quarter, MDVL stock was sold by these institutional investors:
- Pura Vida Investments LLC
Which institutional investors are buying MedAvail stock?
Within the last quarter, MDVL stock was purchased by institutional investors including:
- Cigna Investments Inc. New
- Endurant Capital Management LP
- Millennium Management LLC
- Royce & Associates LP
- Goldman Sachs Group Inc.
- Geode Capital Management LLC
- Morgan Stanley
- Squarepoint Ops LLC